Papers
1
Total Citations
904
H-Index
1
About
Dr. Melissa Ade is a leading gynecologic oncologist whose work has fundamentally advanced the surgical staging of endometrial cancer. Her most impactful contribution is the landmark FIRES trial, a multicentre, prospective cohort study published in 2017 that compared sentinel lymph node biopsy to full lymphadenectomy. With nearly 1,000 citations, this study provided pivotal evidence that sentinel node mapping is a safe and effective alternative, dramatically reducing surgical morbidity for thousands of patients worldwide. Beyond this defining work, Dr. Ade’s research focuses on refining minimally invasive surgical techniques and improving the accuracy of cancer staging to guide adjuvant therapy. Her contributions have reshaped clinical guidelines, making sentinel node biopsy a standard of care. Dr. Ade’s commitment to rigorous, practice-changing research continues to influence how surgeons approach endometrial cancer, balancing oncologic safety with quality of life.
Research Focus
Key Achievements
Top Papers
- 1